Clinical trial Recruiting at 1 site Interventional Ages 20 to 60

Different volumes of the M-TAPA nerve block for pain after sleeve gastrectomy

Official title: Perioperative Analgesic Effect of Different Volumes of Modified Thoracoabdominal Perichondrial Approach on Patients Undergoing Sleeve Gastrectomy: Prospective Randomized Trial

Run by Menoufia University · NCT07510347 · Data updated 2026-11-12

This trial tests whether giving different amounts of local anesthetic with the M-TAPA nerve block reduces pain and opioid use after laparoscopic sleeve gastrectomy.

More Time Restricted Eating trials

Quick facts

Study typeInterventional
Ages20 Years to 60 Years
SexAll
Enrollment60 (estimated)
SponsorMenoufia University
Academic / other
Locations1 site (Shibīn al Kawm, Menofia)
StatusRecruiting
StartedMay 18, 2025
Main results expectedMay 18, 2026
Study endsMay 18, 2026
Registry record updatedApril 3, 2026
Trial IDNCT07510347 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 20–60 years scheduled for elective laparoscopic sleeve gastrectomy with ASA class I–II and no recent chronic opioid use are ideal candidates.

Probably not a fit

Patients with ASA >2, chronic opioid use, prior major abdominal surgery, coagulopathy, local infection, allergy to local anesthetics, or significant neuromuscular or psychiatric disorders are unlikely to be eligible or to benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This single-center prospective randomized trial will enroll 60 adults scheduled for elective laparoscopic sleeve gastrectomy and randomize them to receive bilateral ultrasound-guided modified thoracoabdominal perichondrial approach (M-TAPA) blocks with three different volumes of 0.25% bupivacaine (20, 30, or 40 mL per side). Blocks are performed after induction of standardized general anesthesia and all patients receive standard intraoperative monitoring and postoperative care. Primary outcomes include postoperative pain scores and opioid consumption, with safety and recovery metrics tracked as secondary outcomes. Patients with ASA >2, chronic opioid use, prior major abdominal surgery, coagulopathy, local infection, or relevant neurologic or psychiatric disorders are excluded.

Why it matters

Potential benefit: If successful, the optimized M-TAPA volume could lower postoperative pain and reduce opioid requirements, supporting faster recovery after sleeve gastrectomy.

How similar studies have gone: Regional abdominal blocks such as TAP blocks and early reports of M-TAPA have shown opioid-sparing and improved pain control after abdominal surgery, but randomized data specific to sleeve gastrectomy and optimal M-TAPA volumes remain limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria

Patients will be eligible for the study if they meet the following criteria:

1. Adults aged \> 20 years to 60 years.
2. Scheduled for elective laparoscopic sleeve gastrectomy. Exclusion Criteria

Patients will be excluded from the study if any of the following conditions apply:

1. American Society of Anesthesiology (ASA) ASA \> class 2.
2. History of chronic pain or opioid use for more than 3 months before surgery.
3. Previous major abdominal surgery (which may affect M-TAPA efficacy).
4. Known hypersensitivity or allergy to local anesthetics (e.g., bupivacaine).
5. Coagulopathy or ongoing anticoagulant therapy that could increase bleeding risk.
6. Local infection at the injection site.
7. Neuromuscular disorders affecting pain perception.
8. Patient with mental or psychiatric disorders.

Where it's running

  • Menofia faculty of medicine
    Shibīn al Kawm, Menofia, Egypt
    Recruiting

Study contacts

  • Principal investigator: Ahmed Mohamed elkhouly, bachelor — Menoufia University
  • Study coordinator: Ahmed Mohamed Elkhouly, bachelor's degree
  • Email: xahmed035@gmail.com
  • Phone: +201017829302

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.